Youngy Health Co., Ltd.
Symbole: 300247.SZ
SHZ
2.97
CNYPrix du marché aujourd'hui
68.1562
Ratio P/E
4.6551
Ratio PEG
2.39B
Cap MRK
- 0.00%
Rendement DIV
Youngy Health Co., Ltd. (300247-SZ) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 493.1 | 409.3 | 235.6 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 374 | 341 | 144.3 | ||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 51.8 | 54.3 | 65.6 | ||||||||||||||||||
balance-sheet.row.inventory | 0 | 143.9 | 186.6 | 149.2 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 129.2 | 116.5 | 51 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 818 | 766.7 | 501.4 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 224.9 | 246.1 | 259.4 | ||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 42.8 | 44.9 | 55.5 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 42.8 | 44.9 | 55.5 | ||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | -323 | -290.1 | -10.9 | ||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 7 | 3.1 | 1.9 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 451.9 | 416.1 | 214.7 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 403.5 | 420.1 | 520.7 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 0 | 1221.6 | 1186.8 | 1022.2 | ||||||||||||||||||
balance-sheet.row.account-payables | 0 | 47.4 | 52.7 | 52 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 12 | 10.4 | 7 | ||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 2.7 | 3.6 | 2.7 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 5.4 | 17 | 25.1 | ||||||||||||||||||
Deferred Revenue Non Current | 0 | -19.1 | -15.9 | 0.1 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 1.7 | 2.4 | 1.9 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 24.5 | 32.9 | 33.2 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 5.4 | 17 | 25.1 | ||||||||||||||||||
balance-sheet.row.total-liab | 0 | 148.9 | 158 | 161.1 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.common-stock | 0 | 804 | 804 | 804 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -1200.1 | -1226.7 | -1353 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 45.1 | 66.5 | 35.3 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1367.7 | 1345.1 | 1345.1 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1016.8 | 989 | 831.4 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1221.6 | 1186.8 | 1022.2 | ||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 55.9 | 39.8 | 29.7 | ||||||||||||||||||
balance-sheet.row.total-equity | 0 | 1072.7 | 1028.8 | 861.1 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||
Total Investments | 0 | 50.9 | 50.9 | 133.4 | ||||||||||||||||||
balance-sheet.row.total-debt | 0 | 17.3 | 27.4 | 32.1 | ||||||||||||||||||
balance-sheet.row.net-debt | 0 | -101.8 | -40.9 | -59.2 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 133.3 | 31.4 | -55.3 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 28.4 | 22.6 | 18.6 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 6.7 | 1.9 | 1.1 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -6.7 | -1.9 | -1.1 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -51.9 | -18.9 | 75.4 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | -14.7 | 15.9 | 24.1 | |||||||||||||||||
cash-flows.row.inventory | 0 | -40 | -44 | 3.2 | |||||||||||||||||
cash-flows.row.account-payables | 0 | -3.9 | 7.4 | 47 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | 6.7 | 1.9 | 1.1 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -139.1 | -24.3 | 42.3 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -17.5 | -6.2 | -8.7 | |||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 1.2 | 0.2 | 35.5 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -800.7 | -374.7 | -355.9 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 805.5 | 256.5 | 368.4 | |||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 19.1 | 55 | 0.5 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 7.6 | -69.3 | 39.8 | |||||||||||||||||
cash-flows.row.debt-repayment | 0 | -11.6 | -5.7 | -25 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -0.9 | |||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -11.6 | -5.7 | -10.8 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -11.6 | -5.7 | -36.7 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 10.1 | -4.5 | -10.1 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -23 | -68.7 | 73.9 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 68.3 | 91.3 | 160 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 91.3 | 160 | 86.1 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -29.2 | 10.8 | 81 | |||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -17.5 | -6.2 | -8.7 | |||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -46.7 | 4.6 | 72.3 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 529.4 | 463.3 | 526.5 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 355.5 | 352 | 399.3 | ||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 174 | 111.3 | 127.2 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 13.7 | 4 | 15.3 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 132.2 | 119.2 | 112.2 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 487.6 | 471.2 | 511.5 | ||||||||||||||||||
income-statement-row.row.interest-income | 0 | 7.9 | 2.9 | 2.5 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0.6 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 0.3 | -0.8 | -0.5 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 13.7 | 4 | 15.3 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 0.3 | -0.8 | -0.5 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0.6 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 28 | 28.4 | 22.6 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 0 | 59.4 | 137.2 | 38.3 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 59.8 | 136.4 | 37.8 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 17.8 | 3.1 | 6.3 | ||||||||||||||||||
income-statement-row.row.net-income | 0 | 26.6 | 126.3 | 24.2 |
Questions fréquemment posées
Quel est le total de Youngy Health Co., Ltd. (300247.SZ) de l'actif total?
Youngy Health Co., Ltd. (300247.SZ) Le total des actifs est 1221559067.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est N/A.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.332.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est 0.115.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est 0.066.
Quel est le revenu total de l'entreprise?
Le revenu total est 0.130.
Qu'est-ce que Youngy Health Co., Ltd. (300247.SZ) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est 26582643.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 17332369.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 132173058.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 0.000.